Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenoScreen is a private French genomics and bioinformatics company founded in 2001 and based on the Institut Pasteur campus in Lille. The company provides sequencing, genotyping, metagenomics, transcriptomics, and bioinformatics services for academic and industrial customers across health, microbiology, environment, nutrition, cosmetics, and agri-food markets. It also develops and commercializes proprietary molecular analysis products, including Deeplex® Myc-TB for rapid identification, genotyping, and drug-resistance profiling of Mycobacterium tuberculosis complex, and GenoBiome® solutions for microbiome analysis. GenoScreen appears to operate as a service-and-products business rather than a therapeutics developer, with commercial offerings centered on microbial genomics, molecular diagnostics, and analytical platforms. Its R&D focus includes pathogenic bacteria, antibioresistance, microbial community analysis, and bioinformatic tool development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenoScreen.